Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome

Lupus. 2011 Oct;20(10):1106-8. doi: 10.1177/0961203311400115. Epub 2011 Jun 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Antiphospholipid / blood*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome / blood
  • Antiphospholipid Syndrome / immunology*
  • Antiphospholipid Syndrome / therapy*
  • Down-Regulation
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Platelet Count
  • Rituximab
  • Thrombocytopenia / blood
  • Thrombocytopenia / therapy
  • Young Adult

Substances

  • Antibodies, Antiphospholipid
  • Antibodies, Monoclonal, Murine-Derived
  • Anticoagulants
  • Immunosuppressive Agents
  • Rituximab